← Tra cứu cổ phiếu

iShareInvest Research

UPCOM · Quý 2/2026

HGT

Du lịch Hương Giang

Analysis of business results & financial statements · Quý 2/2026

▼▼ Declining sharply

Trailing net profit reached 17.4bn, fell 84.6bn compared with the same period last year. Offsetting pressure came mainly from lower financial income. Detailed impact is shown below:

See what is changing ↓
P/E
—
P/B
—
EPS
-872
BVPS
9,523
ROE
-8.8%
ROA
-7.0%
Market price
—

What Is Changing

On a TTM 2026Q2 basis, HGT posted a very sharp profit drop versus the same period, showing that pressure has clearly fed through to the bottom line — profit momentum has been slowing across consecutive periods. The key watch now is how long the business needs to stabilize its profit base.

Profit bridge

Vs last year · TTM

  1. Financial income
  2. Other
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 2/2026

MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue16.514.08.16.910.213.313.915.0
LNST-1.05.0-16.8-4.7-0.31.8-9.274.8
Net margin-5.96%35.80%-207.65%-67.55%-2.56%13.78%-66.18%498.32%

Revenue

16bn

Net income

-1bn

Net margin

-5.96%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins narrowed but earnings quality remains clean — pressure is mainly operational.

Revenue Growth

▼

Is growth real and durable?

Trailing-12-month revenue declined 13.0% year on year — not from a single spike: quarterly growth stepped up from −54% to +62%.

2 of the last 4 quarters grew year on year.

Revenue TTM
46bn
−13.0%
Latest quarter YoY
+62%
accelerating

What is driving the margin?

▼▼

Net margin fell to −38.30%, losing 166.7pp. The main pressure comes from SG&A / Revenue rose 22.1pp (with lingering pressure from Net financial result / Revenue fell 145.6pp and Other profit / Revenue fell 1.4pp).

The pressure comes from non-core items while core operations hold their rhythm — margin has a basis to recover once this factor passes.

Net Margin
−38.30%
−166.7pp
Gross Margin
18.09%
−0.9pp
SG&A / Revenue
63.03%
+22.1pp

TTM YoY · 2025Q2 -> 2026Q2

Cash Flow

▼▼

Is profit converting into cash?

Operating cash flow reached -9.5bn against investing cash flow of 20.1bn (annual cash-flow figures for 2025).

Post-investment cash flow was positive +10.5bn. Financing cash flow was negative +2.0bn.

CFO / net income was 0,79 lần.

After spending +23.0bn on fixed-asset investment, the business generated trailing free cash flow of −36.9bn.

Earnings Quality

▲

How much income is non-core?

About 98% of pre-tax profit comes from core operations.

Within that, net financial result at −19.6%, other profit at +2.3% of PBT.

Non-core / PBT
2.3%
low
Net financial / PBT
−19.6%
Other profit / PBT
2.3%
02

Is capital being used efficiently?

Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.

Is capital being deployed efficiently?

●

Track how much operating profit the business generates on invested capital.

Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.

Working Capital Efficiency

▼

Cash conversion cycle lengthened by 29.9 days versus the same period last year. The main moves came from DIO rose 0.7 days, DSO rose 30.9 days, and DPO rose 1.7 days.

Working capital cycle lengthened mainly due to slower receivables collection — receivables quality needs monitoring.

Cash conversion cycle is lengthening

CCC is up by +29.9 days, indicating weaker working-capital turnover versus the prior year.

Receivables collection is slowing

DSO increased by +30.9 days, pointing to slower receivables turnover.

DuPont

What drives ROE?

Net margin -38.3% -166.7pp
Asset turnover 0.18x -0.04x
Financial leverage 1.25x -0.11x
ROE -8.8% -29.9pp

ROE fell from 38.7% to −8.8% — all three components weakened.

03

Is financial risk significant?

Leverage is safe but FCF is negative at 36.9bn due to capex of 23.0bn — an investment choice, not an urgent risk.

Leverage & Liquidity

▼▼

Leverage warrants monitoring, with net debt / equity at −0.23x and interest coverage only at −5.87x.

At present, short-term debt accounts for 11.9% of total debt, cash equals 628.5% of debt, and total debt stands at 8.4bn.

Net Debt / Equity
−0.23x
+0.03x
Interest Coverage
−5.87x
−23.78x
Cash / Debt
628.5%
+5.3pp
Short-term Debt / Total Debt
11.9%
+1.4pp

TTM YoY · 2025Q2 -> 2026Q2

Interest coverage is thin

Interest coverage is −5.87x, leaving limited room to absorb financing costs.

Balance Sheet

▼

Balance sheet is exceptionally sound — liabilities at 0.36x equity, with a net cash position equivalent to 0.23x equity.

None

Over the last 12 months, working capital absorbed 7.6bn of cash, mainly because of higher receivables and higher inventories.

Research synthesis

What this reporting period is showing

The business is under real pressure, but the current picture has not turned broadly adverse. A notable area has clearly weakened, making the near-term outlook hard to call bright; even so, other parts of the business are still holding up, with margins remain under pressure remaining the main constraint, with net margin down 166.7 pp. The next watchpoint is earnings conversion quality, with CFO/NI at 0.79x.

  • Watchpoint: earnings conversion still needs confirmation, with CFO / net income at 0.79x while net financial result still accounts for −19.6% of PBT.
  • Key risk: profitability remains under pressure, with trailing-12M net margin at -38.30% after a 166.7pp decline versus the same period last year.

Questions for the next period

  1. Whether revenue stabilizes after a −13,0% YoY decline or keeps falling.

  2. Whether margins hold around the current -38.30% level or narrow again.

  3. Whether operating cash flow holds its -9.5bn (cumulative for 2025) level in upcoming periods or weakens.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio